Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 1
LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Basic tumor immunology
Original research
LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy
Online download statistics by month:
Online download statistics by month: January 2024 to September 2025
Abstract
Full
Pdf
Jan 2024
353
356
165
Feb 2024
545
549
266
Mar 2024
230
232
138
Apr 2024
179
179
92
May 2024
127
129
57
Jun 2024
201
202
93
Jul 2024
135
135
69
Aug 2024
99
102
147
Sep 2024
131
133
74
Oct 2024
116
117
74
Nov 2024
120
124
65
Dec 2024
145
150
57
Jan 2025
126
127
86
Feb 2025
235
235
76
Mar 2025
148
149
91
Apr 2025
168
168
90
May 2025
101
101
81
Jun 2025
86
86
49
Jul 2025
1
1
0
Sep 2025
2
2
0
Total
3248
3277
1770
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?